Skip to main content

Table 1 Patient baseline characteristics.

From: Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: a case control study

Patient characteristics

Group 1 (1)

Group 2 (1)

Number of patients

9

15

Median age

44

47

Male/Female

7 / 2

11 / 4

Race (Caucasian / Asian)

7 / 2

15 / 0

Pre-treatment RNA HCV

5.5. × 106

7.5 × 106

Genotype 1

All

All

Median ALT at baseline

89

122

Cirrhosis/No-cirrhosis

4 / 5

1 / 14

Previous NR / other *

6 / 3

11 / 4

  1. *) Non-sustained responder to previous therapy or previously untreated patients with cirrhosis and genotype 1.
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us